Psychological stress, distress and disability in patients with psoriasis: Consensus and variation in the contribution of illness perceptions, coping and alexithymia

British Journal of Clinical Psychology

Volumn 41, Issue 2, 2002, Pages 157-174

  Fortune, D G ^a   Richards, H L ^a   Griffiths, C E M ^a   Main, C J ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ALEXITHYMIA; ANAMNESIS; ANXIETY; ARTICLE; COGNITION; CONTROLLED STUDY; COPING BEHAVIOR; DAILY LIFE ACTIVITY; DEMOGRAPHY; DEPRESSION; DISABILITY; DISEASE SEVERITY; DISTRESS SYNDROME; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; OUTCOMES RESEARCH; PRIORITY JOURNAL; PSORIASIS; QUESTIONNAIRE; RATING SCALE; STATISTICAL MODEL; STRESS;

ADAPTATION, PSYCHOLOGICAL; ADOLESCENT; ADULT; AFFECTIVE SYMPTOMS; AGED; ANXIETY; DEPRESSION; DISABILITY EVALUATION; FEMALE; HUMANS; MALE; MIDDLE AGED; PERSONALITY INVENTORY; PSORIASIS; PSYCHOMETRICS; SICK ROLE; STRESS, PSYCHOLOGICAL;

EID: 0036085094     PISSN: 01446657     EISSN: None     Source Type: Journal    
DOI: 10.1348/014466502163949     Document Type: Article

References (69)

1. Prevalence of alexithymic characteristics in psoriatic patients
2. The twenty-item Toronto Alexithymia Scale I. Item selection and cross validation of the factor structure
3. The twenty-item Toronto Alexithymia Scale II. Convergent, discriminant and concurrent validity
4. The nature, functions, and origins of worry
5. Differential effects of worry and imagery after exposure to a stressful stimulus: A pilot study
6. Secondary prevention clinics for coronary heart disease: Randomised trial of effects on health
7. Assessing coping strategies: A theoretically based approach
8. Individual differences, stress and coping
9. A comparison of three worry questionnaires
10. Beliefs about the consequences of worrying
11. Does escape behaviour strengthen agoraphobic avoidance? A preliminary study
12. Psoriasis in Australian twins
13. Worry and problem solving: Evidence of a specific relationship
14. Life events and psychological distress in dermatological disorders: Psoriasis, chronic urticaria and fungal infections
15. The effect of severe psoriasis on the quality of life of 369 patients
16. Validation of sickness impact profile and psoriasis disability index in psoriasis
17. Disease severity measures in a population of psoriasis patients: The symptoms of psoriasis correlate with self administered Psoriasis Area and Severity Index Scores
18. Cognitive, emotional and biomedical features of adjustment in patients with psoriasis: Clinical and experimental investigations
19. Quality of life in patients with psoriasis: The contribution of clinical variables and psoriasis-specific stress
20. Assessing illness related stress in psoriasis: The psychometric properties of the Psoriasis Life Stress Inventory
21. Automatic vigilance for psoriasis-specific and psychosocial threat in patients with psoriasis
22. What patients with psoriasis believe about their condition
23. Pathological worrying, illness perceptions and disease severity in patients with psoriasis
24. A cognitive-behavioural symptom management programme for psoriasis as an adjunct in psoriasis therapy
25. Developing clinical psychology services in an out-patient dermatology clinic: What factors are associated with non-uptake of the service?
26. Severe psoriasis: Oral therapy with a new retinoid
27. Psoriasis and stress: A prospective study
28. Psychological and psychophysiological aspects of psoriasis
29. Feelings of stigmatization in patients with psoriasis
30. Psoriasis, T cells and autoimmunity
31. The Psoriasis Life Stress Inventory: A preliminary index of psoriasis-related stress
32. Pruritus in psoriasis: A prospective study of some psychiatric and dermatologic correlates
33. Suicidal ideation in psoriasis
34. Structure of the twenty-item Toronto Alexithymia Scale
35. Role of patients' illness representations in coping and functioning with Addison's disease
36. Psychiatric symptoms in dermatology patients
37. Health behaviours reported as coping strategies: A factor analytic study
38. Understanding the experiences of people with disfigurements: An integration of four models of social and psychological functioning
39. The Psoriasis Disability Index - Further analyses
40. Is day care equivalent to inpatient care for active rheumatoid arthritis? Randomised controlled clinical and economic evaluation
41. Illness cognition: Using common-sense to understand treatment adherence and affect-cognition interactions
42. The common-sense representation of illness danger
43. Comparison of the General Health Questionnaire and the Hospital Anxiety and Depression Scale
44. Why put new wine in old bottles? The need for a biopsychosocial approach to the assessment, treatment and understanding of unexplained and explained symptoms in medicine
45. Are alexithymia, depression and anxiety distinct constructs in affective disorders
46. Development and validation of the Penn State Worry Questionnaire
47. The factor structure and factor stability of the hospital anxiety and depression scale in patients with cancer
48. Functioning in chronic fatigue syndrome: Do illness perceptions play a regulatory role?
49. Psychosocial effects of vitiligo. A comparison with 'normal' control subjects, with psoriasis patients, and with patients with other pigmentary disorders
50. Psoriasis causes as much disability as other major medical diseases
51. The psychosocial impact of psoriasis: Implications for treatment
52. The contribution of perceptions of stigmatisation to disability in patients with psoriasis
53. Avoidance behaviour is motivated by threat beliefs: A possible resolution of the cognition behaviour debate
54. Illness perceptions, coping and functioning in patients with rheumatoid arthritis, chronic obstructive pulmonary disease and psoriasis
55. Patients' illness perceptions and coping as predictors of functional status in psoriasis: A 1-year follow up
56. The prevalence of 'alexithymic' characteristics in psychosomatic patients
57. An examination of the self-regulation model in atrial fibrillation
58. The transformation of meaning: The interacting cognitive subsystems approach
59. The Illness Perception Questionnaire: A new method for assessing the cognitive representation of illness
60. Attention and the control of worry
61. Social phobia: The role of in-situation safety behaviours in maintaining anxiety and negative beliefs
62. A cognitive model of dysfunctional illness behaviour
63. Alexithymia and its measurement: Confirmatory factor analyses of the 20-item Toronto Alexithymia Scale and the Bermond-Vorst Alexithymia Questionnaire
64. Alexithymia and anxiety sensitivity in panic disorder and obsessive compulsive disorder
65. The Hospital Anxiety and Depression Scale